Latest / GNN Daily Breaking News / Trump Picks Heidi Overton to Lead FDA

Transcript

Trump Picks Heidi Overton to Lead FDA · GNN Daily Breaking News

• 0:00
  Speaker 1: President Donald Trump has selected White House advisor Heidi Overton
• 0:04
  Speaker 1: to lead the Food and Drug Administration. According to a
• 0:07
  Speaker 1: source familiar with the decision, the move places a trusted
• 0:11
  Speaker 1: policy aid at the helm of one of the nation's
• 0:13
  Speaker 1: most influential health agencies, which oversees food safety, pharmaceuticals, and
• 0:19
  Speaker 1: medical devices. Overton, a physician by training, has served as
• 0:24
  Speaker 1: a senior advisor on health policy inside the White House.
• 0:28
  Speaker 1: She has been closely involved in shaping administration initiatives on
• 0:32
  Speaker 1: drug pricing, regulatory reform, and pandemic preparedness. Her appointment signals
• 0:38
  Speaker 1: Trump's preference for loyal insiders rather than career regulators, to
• 0:42
  Speaker 1: guide the FDA's direction. The FDA plays a critical role
• 0:47
  Speaker 1: in approving new medicines and monitoring public health risks. Under
• 0:51
  Speaker 1: Overton's leadership, the agency is expected to continue emphasizing deregulation
• 0:56
  Speaker 1: and faster approval processes pies. Trump has repeatedly championed. Supporters
• 1:03
  Speaker 1: argue that streamlining rules will spur innovation and reduce costs,
• 1:07
  Speaker 1: while critics warn that loosening standards could compromise safety. The
• 1:12
  Speaker 1: nomination comes at a pivotal moment the FDA is grappling
• 1:16
  Speaker 1: with challenges ranging from opioid abuse to oversight of emerging
• 1:20
  Speaker 1: technologies like gene therapies and artificial intelligence. In medicine. Industry
• 1:26
  Speaker 1: leaders are watching closely to see how Overton balances demands
• 1:30
  Speaker 1: for speed with the need for rigorous scientific review. Democrats
• 1:34
  Speaker 1: in Congress are likely to scrutinize the choice, raising questions
• 1:38
  Speaker 1: about her experience and independence. Some lawmakers have already signaled
• 1:43
  Speaker 1: concern that placing a political advisor in charge of the
• 1:46
  Speaker 1: FDA could undermine its credibility as a science driven agency.
• 1:51
  Speaker 1: For Trump, the decision reflects a broader strategy of consolidating
• 1:56
  Speaker 1: control over regulatory bodies. By appointing trustst aids, the administration
• 2:02
  Speaker 1: ensures alignment with its policy goals, even in agencies traditionally
• 2:07
  Speaker 1: insulated from political influence. The nomination will require Senate confirmation,
• 2:12
  Speaker 1: setting up what could be a contentious hearing. Overton's record
• 2:16
  Speaker 1: and policy positions will be examined in detail, with both
• 2:20
  Speaker 1: supporters and opponents preparing to make the case for how
• 2:23
  Speaker 1: her leadership would shape the FDA's future.